ATE255450T1 - Matrix für iontophorese - Google Patents

Matrix für iontophorese

Info

Publication number
ATE255450T1
ATE255450T1 AT96108896T AT96108896T ATE255450T1 AT E255450 T1 ATE255450 T1 AT E255450T1 AT 96108896 T AT96108896 T AT 96108896T AT 96108896 T AT96108896 T AT 96108896T AT E255450 T1 ATE255450 T1 AT E255450T1
Authority
AT
Austria
Prior art keywords
drug
humectant
weight
iontophoresis
proline
Prior art date
Application number
AT96108896T
Other languages
English (en)
Inventor
Yasuyuki Suzuki
Katsumi Iga
Yukihiro Matsumoto
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE255450T1 publication Critical patent/ATE255450T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
AT96108896T 1995-06-09 1996-06-04 Matrix für iontophorese ATE255450T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14298395 1995-06-09
JP20190295 1995-08-08

Publications (1)

Publication Number Publication Date
ATE255450T1 true ATE255450T1 (de) 2003-12-15

Family

ID=26474826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96108896T ATE255450T1 (de) 1995-06-09 1996-06-04 Matrix für iontophorese

Country Status (5)

Country Link
US (2) US5993848A (de)
EP (1) EP0747092B1 (de)
AT (1) ATE255450T1 (de)
CA (1) CA2178445A1 (de)
DE (1) DE69630918T2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0813887A3 (de) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. Iontophoretische Vorrichtung
CA2208332A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. Drug administration composition for iontophoresis
EP0922467A3 (de) 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretische Verabreichung von Medikamenten
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
DE69902713T2 (de) 1998-04-14 2003-05-28 Hisamitsu Pharmaceutical Co Die Verwendung eines GP IIb/IIIa Antagonisten für die Herstellung eines Medikamentes geeignet zur transdermalen Applikation mittels Iontophorese
ATE354376T1 (de) 1999-10-14 2007-03-15 Pola Chem Ind Inc Zusammensetzungen für die elektroporation
DE60031709T2 (de) * 1999-10-14 2007-06-28 Pola Chemical Industries, Inc. Zusammensetzungen für die elektroporation
DE60143945D1 (de) * 2000-07-18 2011-03-10 Cornell Res Foundation Inc Medizinische verwendung von agonisten des mu-opioid rezeptors
US6801804B2 (en) 2002-05-03 2004-10-05 Aciont, Inc. Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
US7099713B2 (en) 2002-06-28 2006-08-29 Battelle Memorial Institute Skin conduction and transport systems
EP2491943B1 (de) 2003-02-04 2018-10-10 Cornell Research Foundation, Inc. Verfahren zum Verhindern des Übergangs der Mitochondrienpermeabilität
CA2524258C (en) 2003-05-01 2012-08-07 Cornell Research Foundation, Inc. Carrier complexes comprising cationic peptides for delivering molecules to cells
JP4931604B2 (ja) * 2004-01-23 2012-05-16 コーネル リサーチ ファウンデイション インコーポレイテッド 酸化的損傷を低減する方法
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
DE102005024040A1 (de) * 2005-05-25 2006-12-14 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
US20080274166A1 (en) * 2005-06-10 2008-11-06 Transpharma Medical Ltd. Patch for Transdermal Drug Delivery
CA2947335A1 (en) 2005-09-16 2007-03-29 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
CA2696227A1 (en) * 2007-10-17 2009-04-23 Transpharma Medical Ltd. Dissolution rate verification
WO2009057112A2 (en) 2007-10-29 2009-05-07 Transpharma Medical, Ltd. Vertical patch drying
CA2713150C (en) 2008-02-07 2016-01-05 Cornell University Methods for preventing or treating insulin resistance
CN106975070A (zh) 2008-02-26 2017-07-25 康奈尔大学 用于防止和治疗急性肾损伤的方法
CN102099475A (zh) * 2008-06-04 2011-06-15 科达治疗公司 用间隙连接调节化合物治疗疼痛
CN103933542A (zh) 2009-03-20 2014-07-23 通用医疗公司以马萨诸塞州通用医疗公司名义经营 预防和治疗烧伤损伤和继发性并发症的方法
JP5909182B2 (ja) * 2009-08-12 2016-04-26 コーネル ユニヴァーシティー 代謝性症候群を予防し又は治療するための方法
EP3318264A1 (de) 2009-08-24 2018-05-09 Stealth Peptides International, Inc. Verfahren und zusammensetzungen zur prävention oder behandlung ophthalmischer leiden
EP2944317A1 (de) * 2009-10-05 2015-11-18 Cornell University Verfahren zur Prävention und Behandlung von Herzinsuffizienz
US9362378B2 (en) 2011-10-28 2016-06-07 Indian Institute Of Technology Madras Piezoelectric devices and methods for their preparation and use
EP2831233A1 (de) 2012-03-27 2015-02-04 CoDa Therapeutics, Inc. Zusammensetzungen und behandlungen auf der basis von cadherin-modulation
CN104768567B (zh) 2012-05-18 2017-07-11 奥塔哥创业有限公司 用于伤口愈合的联合治疗和组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5612347A (en) * 1988-03-28 1997-03-18 Janssen Pharmaceutica N.V. Agents for preserving or restoring the soundness of the skin
CA2026885C (en) * 1989-02-06 1998-12-01 Keiichirou Okabe Interface for iontophorese
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
WO1993010163A2 (en) * 1991-11-12 1993-05-27 Nepera, Inc. Adhesive hydrogels having extended use lives and process for the preparation of same
ATE169826T1 (de) * 1992-01-21 1998-09-15 Macrochem Corp Iontophoretische verbesserte verabreichung von medikamenten
JPH08501529A (ja) * 1992-06-11 1996-02-20 セラテック・インコーポレイテッド 皮膚透過薬剤投与緩和のグリセリン使用
JPH0616535A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼ用インターフェイス
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
US5932227A (en) * 1992-07-23 1999-08-03 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable base composition and drug composition prepared therefrom
EP0643981B1 (de) * 1993-09-22 2002-01-09 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix
US5472958A (en) * 1994-08-29 1995-12-05 Abbott Laboratories 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

Also Published As

Publication number Publication date
US6248349B1 (en) 2001-06-19
EP0747092A2 (de) 1996-12-11
EP0747092A3 (de) 1998-04-08
CA2178445A1 (en) 1996-12-10
DE69630918D1 (de) 2004-01-15
DE69630918T2 (de) 2004-10-28
EP0747092B1 (de) 2003-12-03
US5993848A (en) 1999-11-30

Similar Documents

Publication Publication Date Title
DE69630918D1 (de) Matrix für Iontophorese
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
ATE196092T1 (de) Wachstumshormon-enthaltendeproteinformulierung
DE69434418D1 (de) Orale Dareichungsform
KR880009632A (ko) 폴리펩티드의 전해식 경피투여
CA2275890A1 (en) Stable liquid interferon formulations
DE69831785D1 (de) Tulobuterol enthaltendes Präparat für perkutane Absorption
DE69417397T2 (de) Lösung, die igf-1 enthält
US6399566B1 (en) Topical preparation for introducing insulin in living organisms
ATE226832T1 (de) Mittel zur arzneistoffverabreichung durch iontophorese
OA12322A (en) Topical pharmaceutical preparation.
TH19245A (th) วิธีป้องกันการสลายของโปรตีนซี
CA2153787A1 (en) Solution containing igf-1
TH25313A (th) องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่
TH14574EX (th) สารผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties